Compliance with the Federal Anti-kickback and Beneficiary Inducement Statutes

The federal Anti-Kickback and Beneficiary Inducement Statutes significantly restrict the marketing of pharmaceutical products. We assist our clients in Anti-Kickback- and Beneficiary Inducement-related compliance by evaluating marketing and other business practices to ensure compliance with the laws’ various safe harbors and other exceptions.